Antonio J Vallejo-Vaz

London, United Kingdom


Monday 27 May 15:45

LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL

Late Breaking session on pharmacology of dyslipidemia